Rebecca C. Keith, MD Make an Appointment Ask a Question Refer Patient Rebecca C. Keith, MD, is a pulmonologist at National Jewish Health. Dr. Keith is in the Division of Pulmonary, Critical Care and Sleep Medicine. Associate Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine Interstitial Lung Disease Program Autoimmune Lung Center 5280 Top Doctors 2021 Previously a 5280 Top Doctor America’s Top Doctors 2015 — Castle Connolly, Medical, Ltd. Recognized in America’s Top Doctors — Castle Connolly, Inc. Best Doctors in America® 2019-2020 — Best Doctors, Inc. Recognized in Best Doctors in America® — Best Doctors, Inc. America’s Top Doctors 2020 — Castle Connolly Medical, Ltd. Email Profile Print Profile Patient Rating 4.7 out of 5 stars 190 Patient Ratings Overview Contact Info & Locations Patient Ratings & Comments Programs & Services Center for Post-COVID Care and Recovery Department of Medicine Division of Pulmonary, Critical Care and Sleep Medicine (Adult) Interstitial Lung Disease (ILD) Program Pulmonary Physiology Services Scleroderma Program Specialties & Conditions Autoimmune Lung Diseases Bronchiolitis Obliterans Dyspnea (Shortness of Breath) Eosinophilic Lung Diseases Hypersensitivity Pneumonitis Interstitial Lung Disease (ILD)/Pulmonary Fibrosis Obstructive Sleep Apnea (OSA) Sarcoidosis Overview Unexplained Hypoxia Research Areas Autoimmune Lung Diseases Idiopathic Pulmonary Fibrosis (IPF) Interstitial Lung Disease (ILD)/Pulmonary Fibrosis Special Interests My goal is to contribute to the understanding of the pathogenesis of Idiopathic Pulmonary Fibrosis and autoimmune lung disease via basic, translational, and clinical research with the ultimate aim to improve quality of life for patients with pulmonary fibrosis. I have a strong interest in autoimmune lung disease and the intersection between innate immunity and the development of fibrotic lung disease. Education Education 1999 - 2003 Weill Medical College of Cornell University, New York, NY, MD Residency 2006 - 2007 Emory University School of Medicine, Atlanta, GA, Chief Resident 2003 - 2006 Emory University School of Medicine, Atlanta, GA, Fellowship 2010 - 2011 University of Colorado Denver School of Medicine, Research Fellowship 2007 - 2010 University of Colorado Denver School of Medicine, Awards & Recognition 2011: American Thoracic Society Travel Award, American Thoracic Society 2006: Chief Resident, Emory School of Medicine 2006: Ambulatory Clinic Physician Award- Awarded for outstanding ambulatory clinical care, professionalism, conference attendance and participation, Emory University School of Medicine 2003: Alfred Moritz Michaelis Prize in Medicine- Awarded for "general efficiency" in Medicine, Weill Medical College of Cornell University 1998: Graduation with distinction in all subjects, Cornell University 1997: Golden Key International Honor Society, Cornell University 1994-1998: Isabel Peard Cornell Tradition Fellow, Cornell University 1994-1998: Mening Family Cornell National Scholar, Cornell University Board Certification 2010: Internal Medicine-Critical Care Medicine 2009: Internal Medicine-Pulmonary Disease 2007: Internal Medicine Professional Memberships American Thoracic Society American College of Chest Physicians Publications Redente EF, Jacobsen KM, Solomon JJ, Lara AR, Faubel S, et al. Age and sex dimorphisms contribute to the severity of bleomycin-induced lung injury and fibrosis. American journal of physiology. Lung cellular and molecular physiology. 2011; 301(4):L510-8.PMID:21743030. PMCID: PMC3191751. Keith RC, Powers JL, Redente EF, Sergew A, Martin RJ, et al.A novel model of rheumatoid arthritis-associated interstitial lung disease in SKG mice.Experimental lung research. 2012; 38(2):55-66.PMID:22185348. Keith RC, Sokolove J, Edelman BL, Lahey L, Redente EF, et al. Testosterone is protective in the sexually dimorphic development of arthritis and lung disease in SKG mice. Arthritis and rheumatism. 2013; 65(6):1487-93. NIHMSID: NIHMS457088. PMID:23529475. PMCID:PMC3672393. Roy MG, Livraghi-Butrico A, Fletcher AA, McElwee MM, Evans SE, et al. Muc5b is required for airway defence.Nature. 2014; 505(7483):412-6. NIHMSID: NIHMS571052. PMID:24317696. PMCID:PMC4001806. Redente EF, Keith RC, Janssen W, Henson PM, Ortiz LA, et al.Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.American journal of respiratory cell and molecular biology. 2014; 50(4):825-37. PMID:24325577. PMCID:PMC4068926. Academic Affiliations Full faculty appointment, University of Colorado Denver Teaching & Professional Positions Assistant Professor, VA Eastern Colorado Health Care System Languages English Conflicts of Interest National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians or scientists. View this faculty member’s industry relationships and collaborations. Ask a Question through Patient Portal Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account Contact Information Office: 877.225.5654 Locations National Jewish Health Main Campus 1400 Jackson St. Denver, CO 80206 Patient Ratings The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes. Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey. Provider showed concern 4.7 Friendliness 4.8 Spoke using clear language 4.8 Provider explained things clearly 4.6 Amount of time spent with you 4.5 Provider included you in decisions 4.6 Confidence in your doctor 4.7 Likelihood of recommending this provider 4.7 Comments Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.